Insmed Inc Stock Analysis

INSM Stock  USD 26.82  0.43  1.58%   
Insmed Inc is undervalued with Real Value of 30.86 and Target Price of 42.58. The main objective of Insmed stock analysis is to determine its intrinsic value, which is an estimate of what Insmed Inc is worth, separate from its market price. There are two main types of Insmed's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Insmed's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Insmed's stock to identify patterns and trends that may indicate its future price movements.
The Insmed stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Insmed is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Insmed Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Insmed's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Insmed Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.34. Insmed Inc had not issued any dividends in recent years. The entity had 1:10 split on the 3rd of March 2011. Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey. Insmed operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 613 people. To learn more about Insmed Inc call William Lewis at 908 977 9900 or check out https://www.insmed.com.

Insmed Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Insmed's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Insmed Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Insmed Inc generated a negative expected return over the last 90 days
Insmed Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 305.21 M. Net Loss for the year was (749.57 M) with profit before overhead, payroll, taxes, and interest of 190.23 M.
Insmed Inc currently holds about 554.87 M in cash with (536.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62.
Insmed Inc has a very weak financial position based on the latest SEC disclosures
Over 99.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: What Makes Insmed a Lucrative Investment

Insmed Inc Upcoming and Recent Events

Earnings reports are used by Insmed to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Insmed previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Insmed Largest EPS Surprises

Earnings surprises can significantly impact Insmed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2013-08-06
2013-06-30-0.32-0.280.0412 
2015-05-07
2015-03-31-0.5-0.55-0.0510 
2014-05-08
2014-03-31-0.41-0.360.0512 
View All Earnings Estimates

Insmed Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Insmed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Insmed Inc backward and forwards among themselves. Insmed's institutional investor refers to the entity that pools money to purchase Insmed's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2023-12-31
3.1 M
Suvretta Capital Management, Llc2023-12-31
2.7 M
Bank Of New York Mellon Corp2023-12-31
2.4 M
Loomis, Sayles & Company Lp2023-12-31
2.3 M
Bellevue Group Ag2023-12-31
2.3 M
Ameriprise Financial Inc2023-12-31
2.3 M
Alliancebernstein L.p.2023-12-31
2.1 M
Pictet Asset Manangement Sa2023-12-31
M
Rtw Investments, Llc2023-12-31
1.9 M
Vanguard Group Inc2023-12-31
14.1 M
Blackrock Inc2023-12-31
11.5 M
Note, although Insmed's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Insmed Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Insmed's market, we take the total number of its shares issued and multiply it by Insmed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Insmed Profitablity

Insmed's profitability indicators refer to fundamental financial ratios that showcase Insmed's ability to generate income relative to its revenue or operating costs. If, let's say, Insmed is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Insmed's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Insmed's profitability requires more research than a typical breakdown of Insmed's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (2.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.94) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.94.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.66)(0.70)
Return On Capital Employed(0.64)(0.61)
Return On Assets(0.56)(0.59)
Return On Equity 2.26  2.37 

Management Efficiency

Insmed Inc has return on total asset (ROA) of (0.285) % which means that it has lost $0.285 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (14.5341) %, meaning that it created substantial loss on money invested by shareholders. Insmed's management efficiency ratios could be used to measure how well Insmed manages its routine affairs as well as how well it operates its assets and liabilities. As of the 16th of April 2024, Return On Equity is likely to grow to 2.37, while Return On Tangible Assets are likely to drop (0.70). At this time, Insmed's Intangibles To Total Assets are very stable compared to the past year. As of the 16th of April 2024, Debt To Assets is likely to grow to 0.95, though Net Tangible Assets are likely to grow to (127.7 M).
Last ReportedProjected for Next Year
Book Value Per Share(2.36)(2.25)
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share(3.79)(3.60)
Enterprise Value Over EBITDA(7.53)(7.90)
Price Book Value Ratio(13.11)(12.46)
Enterprise Value Multiple(7.53)(7.90)
Price Fair Value(13.11)(12.46)
Enterprise Value746.7 M425.4 M
The analysis of Insmed's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Insmed's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Insmed Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
0.915

Technical Drivers

As of the 16th of April 2024, Insmed retains the Risk Adjusted Performance of (0.01), market risk adjusted performance of (0.03), and Standard Deviation of 2.27. Insmed technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We are able to interpolate and collect thirteen technical drivers for Insmed Inc, which can be compared to its competitors. Please check out Insmed Inc market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Insmed is priced fairly, providing market reflects its last-minute price of 26.82 per share. Given that Insmed Inc has information ratio of (0.05), we strongly advise you to confirm Insmed Inc's regular market performance to make sure the company can sustain itself at a future point.

Insmed Inc Price Movement Analysis

Execute Study
null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Insmed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Insmed Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Insmed Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Insmed insiders, such as employees or executives, is commonly permitted as long as it does not rely on Insmed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Insmed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Insmed Outstanding Bonds

Insmed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Insmed Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Insmed bonds can be classified according to their maturity, which is the date when Insmed Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Insmed Predictive Daily Indicators

Insmed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Insmed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Insmed Corporate Filings

1st of April 2024
Other Reports
ViewVerify
8K
11th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
29th of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
22nd of February 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
13A
16th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
13th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
25th of January 2024
An amended filing to the original Schedule 13G
ViewVerify

Insmed Forecast Models

Insmed's time-series forecasting models are one of many Insmed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Insmed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Insmed Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Insmed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Insmed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Insmed. By using and applying Insmed Stock analysis, traders can create a robust methodology for identifying Insmed entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(2.45)(2.57)
Operating Profit Margin(2.33)(2.44)
Net Loss(2.46)(2.58)
Gross Profit Margin 0.79  0.55 

Current Insmed Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Insmed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Insmed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
42.58Strong Buy16Odds
Insmed Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Insmed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Insmed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Insmed Inc, talking to its executives and customers, or listening to Insmed conference calls.
Insmed Analyst Advice Details

Insmed Stock Analysis Indicators

Insmed Inc stock analysis indicators help investors evaluate how Insmed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Insmed shares will generate the highest return on investment. By understating and applying Insmed stock analysis, traders can identify Insmed position entry and exit signals to maximize returns.
Begin Period Cash Flow1.1 B
Long Term Debt1.2 B
Common Stock Shares Outstanding140.4 M
Total Stockholder Equity-331.9 M
Tax Provision2.6 M
Property Plant And Equipment Net104.4 M
Cash And Short Term Investments780.4 M
Cash482.4 M
Accounts Payable65.4 M
Net Debt721.6 M
50 Day M A27.6724
Total Current Liabilities225.6 M
Other Operating Expenses986.1 M
Non Current Assets Total400.8 M
Non Currrent Assets Other96.6 M
Stock Based Compensation74.8 M
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.34)
Revenue Per Share
2.173
Quarterly Revenue Growth
0.411
Return On Assets
(0.28)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.